These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12627334)

  • 1. --to: M. Koopmanschap: Coping with Type 2 diabetes: the patient's perspective. Diabetologia 45:S18-S22.
    Pouwer F; Adriaanse MC
    Diabetologia; 2003 Feb; 46(2):302-3. PubMed ID: 12627334
    [No Abstract]   [Full Text] [Related]  

  • 2. Coping with Type II diabetes: the patient's perspective.
    Koopmanschap M;
    Diabetologia; 2002 Jul; 45(7):S18-22. PubMed ID: 12136407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coping styles and quality of life in patients with non-insulin-dependent diabetes mellitus.
    Coelho R; Amorim I; Prata J
    Psychosomatics; 2003; 44(4):312-8. PubMed ID: 12832597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes.
    Vinik AI; Zhang Q
    Diabetes Care; 2007 Apr; 30(4):795-800. PubMed ID: 17259481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and therapy in type 2 diabetes.
    French L
    J Fam Pract; 1999 Oct; 48(10):747-8. PubMed ID: 12224666
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus].
    Kishikawa H; Araki E; Wake N; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():140-5. PubMed ID: 12386985
    [No Abstract]   [Full Text] [Related]  

  • 7. [Patient satisfaction in diabetes mellitus--measures and results].
    Kohlmann T; Moock J
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S120-3; discussion S124-6. PubMed ID: 18686221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of life of diabetic patients with intensified insulin therapy].
    Rose M; Schirop T; Klapp BF
    Versicherungsmedizin; 1997 Feb; 49(1):9-13. PubMed ID: 9133033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.
    Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V
    J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of life and hypoglycemia burden in patients with type 2 diabetes mellitus on basal-bolus insulin therapy].
    Ionova TI; Odin VI; Nikitina TP; Kurbatova KA
    Klin Med (Mosk); 2014; 92(10):52-9. PubMed ID: 25782322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes.
    Berger M; Jörgens V; Mühlhauser I
    Diabetes Care; 1999 Apr; 22 Suppl 3():C71-5. PubMed ID: 10189566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
    Currie CJ; Johnson JA
    Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypoglycaemia in insulin-treated Type 2 diabetes.
    Geddes J; Frier BM
    Diabet Med; 2007 Mar; 24(3):327; author reply 328. PubMed ID: 17305795
    [No Abstract]   [Full Text] [Related]  

  • 16. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C
    Diabetes Educ; 2006; 32(6):910-7. PubMed ID: 17102158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the controversies of insulin therapy in patients with type 2 diabetes mellitus.
    Kuritzky L; Nelson SE
    J Fam Pract; 2005 Jun; 54(6):S3-6. PubMed ID: 16021782
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes, insulin therapy, and colorectal cancer.
    Renehan AG; Shalet SM
    BMJ; 2005 Mar; 330(7491):551-2. PubMed ID: 15760973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.